The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE) Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002
Thoracoscopic talc poudrage induces T-lymphopenia Source: Annual Congress 2005 - What's new in the pleura Year: 2005
Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009
Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004
Interleukin-16 in tuberculous and malignant pleural effusions Source: Eur Respir J 2005; 25: 605-611 Year: 2005
Treatment successes with talc pleurodesis at patients (pts.) with recurrent malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002
Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE) Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006
Day case rapid pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021
Thoracoscopic talc pleurodesis‘(TTP) safety and clinical efficacy in malignant pleural effusions (MPE) Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012
Efficacy of talc pleurodesis in patients with malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP) Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016
Thoracoscopic talc poudrage (TTP) in malignant (M) pleural effusion (PE): when to perform it? Source: International Congress 2019 – Interventional pulmonology: current pleural practice Year: 2019
Malignant pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177 Year: 2002
The value of thoracoscopy in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 516s Year: 2001
Effecs of systemic inflammation markers for determining success of talc pleurodeisis on patients with malignant pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003
Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
Analysis of T-cell subsets in patients with tuberculous pleural effusions Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis Year: 2005